Beryl Manning‐Geist
0000-0002-5556-0457
Publication & Citation Trends
Publications
0 total
Evaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancer.
Cited by 0
Semantic Scholar
A PHASE 3, OPEN-LABEL RANDOMIZED TRIAL TO COMPARE RINATABART SESUTECAN VERSUS INVESTIGATOR'S CHOICE OF CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER: RAINFOL™-02 (ENGOT-OV86/GOG-3107)
Cited by 1
Semantic Scholar
Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-Grade Serous Tumors with Histologic Transformation.
Cited by 5
Semantic Scholar
Risk factors and clinical outcomes of radiation-induced fistula after chemoradiation and image-guided brachytherapy for locally advanced cervical cancer
Cited by 0
Semantic Scholar
FF001/#960 Near-infrared fluorescence assessment of myocutaneous flap microperfusion for gynecologic reconstruction: final analysis of a prospective non-randomized surgical trial
Cited by 0
Semantic Scholar
Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities.
Cited by 18
Semantic Scholar
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses OA
Cited by 21
Semantic Scholar
Folate receptor positivity in low-grade serous ovarian cancer: Exploring new therapeutic possibilities
Cited by 0
Semantic Scholar
Research Topics
Ovarian cancer diagnosis and treatment
(66)
Endometrial and Cervical Cancer Treatments
(28)
Intraperitoneal and Appendiceal Malignancies
(12)
Cancer Genomics and Diagnostics
(11)
Genetic factors in colorectal cancer
(11)
Affiliations
Brigham and Women's Hospital
Memorial Sloan Kettering Cancer Center
Harvard University
Emory University
Williams College